iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (SBIO) – Biotech ETFs Hit New 2015 Highs

The biotech momentum story continues to be one of the most persistent themes over the last several years. The diversified indices that track these companies have been consistent market leaders, and investors that have stuck with these stocks have been richly rewarded.

On Thursday, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) hit a new all-time high as it surged more than 3 percent intra-day. This ETF is the largest dedicated biotech industry fund, with nearly $9 billion in total assets.

Top Biotech ETF

IBB tracks a market-cap weighted index of top healthcare names such as Gilead Sciences, Inc. (NASDAQ: GILD) and Amgen, Inc. (NASDAQ: AMGN). These companies are engaged in the fight to cure diseases and develop lifesaving drugs, but the story that investors are cheering is their year-to-date performance.

Related Link: Suntrust’s 5 Biotech Picks For The Next 6 Months

So far in 2015, IBB has gained more than 24 percent and

... read more at: https://www.benzinga.com/general/biotech/15/06/5606677/biotech-etfs-hit-new-2015-highs

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (SBIO) – Biotech ETFs Hit New 2015 Highs

The biotech momentum story continues to be one of the most persistent themes over the last several years. The diversified indices that track these companies have been consistent market leaders, and investors that have stuck with these stocks have been richly rewarded.

On Thursday, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) hit a new all-time high as it surged more than 3 percent intra-day. This ETF is the largest dedicated biotech industry fund, with nearly $9 billion in total assets.

Top Biotech ETF

IBB tracks a market-cap weighted index of top healthcare names such as Gilead Sciences, Inc. (NASDAQ: GILD) and Amgen, Inc. (NASDAQ: AMGN). These companies are engaged in the fight to cure diseases and develop lifesaving drugs, but the story that investors are cheering is their year-to-date performance.

Related Link: Suntrust’s 5 Biotech Picks For The Next 6 Months

So far in 2015, IBB has gained more than 24 percent and

... read more at: https://www.benzinga.com/general/biotech/15/06/5606677/biotech-etfs-hit-new-2015-highs